Hemodynamic Effects of Delayed Umbilical Cord Clamping in Full-term

Status Completed

Clinical Trial Summary

The sequence of events at the time of delivery includes delivery of the infant, clamping of the umbilical cord, and lastly delivery of the placenta. There are some benefits for delayed cord clamping. This study aims to compare the effects of two different duration of delayed cord clamping.

Infants will be randomized into two groups based on the duration of delayed cord clamping: 30 seconds vs 120 seconds. Different hemodynamic effects will be measured in each group at different time intervals. The hypothesis of the study is that delayed cord clamping for 120 seconds is associated with better cardiac output and with other hemodynamic advantages.

Clinical Trial Description

The study will include full term infants delivered via cesarean section. Written informed consent for participation in the study will be obtained from parents prior to delivery. Newborns will be randomly assigned into two groups according to the duration of cord clamping: Group 1: the cord will be clamped at 30 seconds, and Group 2: the cord will be clamped at 120 seconds of life. Stopwatch will be started when infants buttocks (or head if breech) are delivered from the uterus. The time elapsed will be counted aloud by the investigator in 10-second intervals. During this time, the infant will be held in linen on the mothers legs. Care will be taken not to apply traction on the cord. Milking of the cord will not be allowed. Immediately after resuscitation, infants will be attached to the leads of the electrical cardiometry device. Device output will be imported at 5, 10, and 15 minutes after birth in both groups. A follow up measurement will be imported later at 24 hours of age. In addition, a peripheral blood sample will be obtained at 24 hours of age for assessment of hemoglobin, glucose and bilirubin concentrations. .

The calculated sample size is 31 newborns in each group. This number will be adequate to detect an effect size of 10% in the mean cardiac output between the two groups with 95% confidence and 80% power. The study plans to recruit 34 infants in each group (10% attrition rate). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04358822
Study type	Interventional
Source	Cairo University
Contact
Status	Completed
Phase	N/A
Start date	January 21, 2020
Completion date	March 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05070819` - Atrial Natriuretic Peptide in Assessing Fluid Status	N/A
Recruiting	`NCT05492968` - The Effect of Epinephrine, Norepinephrine and Phenylephrine on Intraoperative Hemodynamic Performance	Phase 4
Completed	`NCT03444545` - Continous Cardiac Output - Non-Invasive Evaluation (CONNIE)
Recruiting	`NCT04064177` - Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study
Withdrawn	`NCT03058653` - Use of a Mini-fluid Bolus to Identify Fluid Responsiveness	N/A
Completed	`NCT02880683` - Cardiac Output Autonomic Stimulation Therapy for Heart Failure (COAST-HF) - Human NeuroCatheter Study	N/A
Recruiting	`NCT00989508` - Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy	Phase 2/Phase 3
Completed	`NCT04955184` - Comparing Cardiac Output Measurements Using a Wearable, Wireless, Non-invasive PPG-Based Device to a Swan Ganz Catheter
Completed	`NCT02964663` - Comparison of the Ability of the esCCO and the Volume View to Measure Trends in Cardiac Output During Cardiac Surgery	N/A
Completed	`NCT04641949` - Methoxyflurane and Fentanyl in LBNP	Phase 4
Recruiting	`NCT04191408` - Predictive Ability of PEEP Induced Changes in CVP to Predict Volume Responsiveness in Mechanically Ventilated Patients After Major Abdominal Surgery	N/A
Completed	`NCT01892696` - Effects of Inspiratory Flow Waveforms on Preload	N/A
Recruiting	`NCT02728791` - Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary Thermodilution	N/A
Completed	`NCT03930979` - The Effect of Hyperoxia on Cardiac Output
Recruiting	`NCT04755764` - Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
Enrolling by invitation	`NCT02702544` - Effect of Passive Leg Raising for Fluid Responsiveness	N/A
Completed	`NCT01880684` - Validation of Capnography as a Predictor of Cardiac Output Change as Measured by FloTrac	Phase 2
Recruiting	`NCT05035719` - Comparison Studies Comparing Hemodynamic Parameters Provided by the Caretaker Against Respective Gold Standard References
Not yet recruiting	`NCT04774978` - Real-time Continuous Cardiac Output Measurements	N/A
Completed	`NCT02485782` - Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal on Hemodialysis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Hemodynamic Effects of Delayed Umbilical Cord Clamping in Full-term Newborns

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms